Precigen (PGEN) Gross Margin (2013 - 2026)
Precigen's (PGEN) quarterly Gross Margin came in at 88.99% in Q1 2026, up 7102.0% year-on-year from 1.24% in Q1 2025, and up 11.65% on a QoQ basis from 79.71% in Q4 2025.
Precigen (PGEN) Gross Margin (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Gross Margin data on file, last reported at 88.99% in Q1 2026.
- On a quarterly basis, Gross Margin rose 7102.0% year-over-year to 88.99% in Q1 2026; TTM through Mar 2026 was 80.87%, a 5553.0% increase from a year earlier, with the FY2025 full-year figure at 50.2%, up 5891.0% from the prior year.
- Gross Margin for Q1 2026 stood at 88.99%, up from 79.71% in the prior quarter.
- Over the last five years, Gross Margin for PGEN reached as high as 108.64% in Q4 2022 and fell as low as 153600.0% in Q3 2023.
- Historically, Gross Margin has averaged 15871.17% across 5 years, with a median of 10.97% in 2023.
- Across the five-year window, Gross Margin sank 15368922 bps in 2023 and surged 10079013 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 108.64% in 2022, then slumped by 110 bps to 10.59% in 2023, then soared by 745 bps to 68.32% in 2024, then climbed by 17 bps to 79.71% in 2025, then advanced by 12 bps to 88.99% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 88.99% in Q1 2026, 79.71% in Q4 2025, and 9.87% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 88.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.99% |
| Dec 31, 2025 | 79.71% |
| Sep 30, 2025 | -9.87% |
| Jun 30, 2025 | -39.82% |
| Mar 31, 2025 | 17.97% |
| Dec 31, 2024 | 68.32% |
| Sep 30, 2024 | -100,800.00% |
| Jun 30, 2024 | -41.42% |
| Mar 31, 2024 | -0.94% |
| Dec 31, 2023 | -10.59% |
| Sep 30, 2023 | -153,600.00% |
| Jun 30, 2023 | 3.96% |
| Dec 31, 2022 | 108.64% |
| Sep 30, 2022 | 89.22% |
| Jun 30, 2022 | 37.79% |
| Mar 31, 2022 | 69.27% |
| Dec 31, 2021 | 144.05% |
| Sep 30, 2021 | 85.54% |
| Jun 30, 2021 | 76.04% |
| Mar 31, 2021 | 77.26% |